Kaleen Barbary
About Kaleen Barbary
Kaleen Barbary is the Director of Worldwide Scientific Content & US Market Capabilities in Hematology at Bristol Myers Squibb, with over a decade of experience in medical information and strategy roles within the pharmaceutical industry.
Title and Current Role
Kaleen Barbary holds the title of Director of Worldwide Scientific Content & US Market Capabilities for Hematology. She is currently employed at Bristol Myers Squibb, located in Summit, New Jersey, United States.
Work History at Celgene
Kaleen Barbary has an extensive work history at Celgene, where she held the positions of Director Multiple Myeloma Lead Global Medical Information Hematology/Oncology from 2019 to 2020, Associate Director Multiple Myeloma Lead Global Medical Information Hematology/Oncology from 2018 to 2020, and Associate Director Inflammation & Immunology Global Medical Information from 2017 to 2018. All roles were based in Summit, New Jersey.
Past Roles at Bristol Myers Squibb
Before her current role, Kaleen Barbary held various positions at Bristol Myers Squibb. These included Associate Director, Immunoscience Worldwide Medical from 2014 to 2017 in Princeton, NJ, Associate Director, Cardiovascular Medical Strategy for 9 months in 2014 in Plainsboro, NJ, Manager, Immunoscience Medical Strategy from 2012 to 2014, and Medical Information Specialist; Immunoscience from 2010 to 2012.
Education and Early Career
Kaleen Barbary earned her Pharm D from Rutgers, The State University of New Jersey, specifically the Ernest Mario School of Pharmacy, where she studied from 2006 to 2009. Her early career included a role as a Medical Information Specialist in the Pharmaceutical Industry Fellowship Program at Rutgers focused on CV/Metabolics from 2009 to 2010.
Industry Expertise
With over a decade of experience, Kaleen Barbary has transitioned from cardiovascular medical strategy to immunoscience, and later to hematology. She has significant expertise in managing scientific content and market capabilities within the US market and has held multiple leadership roles in global medical information for hematology/oncology at Celgene.